- Home
- CLRO vs APLM Comparison
CLRO vs APLM Comparison
Compare CLRO & APLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRO
- APLM
- Stock Information
- Founded
- CLRO 1983
- APLM 2016
- Country
- CLRO United States
- APLM United States
- Employees
- CLRO N/A
- APLM N/A
- Industry
- CLRO Radio And Television Broadcasting And Communications Equipment
- APLM Blank Checks
- Sector
- CLRO Technology
- APLM Finance
- Exchange
- CLRO Nasdaq
- APLM Nasdaq
- Market Cap
- CLRO 12.5M
- APLM 6.9M
- IPO Year
- CLRO N/A
- APLM N/A
- Fundamental
- Price
- CLRO $9.31
- APLM $6.00
- Analyst Decision
- CLRO
- APLM
- Analyst Count
- CLRO 0
- APLM 0
- Target Price
- CLRO N/A
- APLM N/A
- AVG Volume (30 Days)
- CLRO 2.1M
- APLM 27.5K
- Earning Date
- CLRO 08-14-2025
- APLM 08-13-2025
- Dividend Yield
- CLRO N/A
- APLM N/A
- EPS Growth
- CLRO N/A
- APLM N/A
- EPS
- CLRO N/A
- APLM N/A
- Revenue
- CLRO $10,077,000.00
- APLM $198,000.00
- Revenue This Year
- CLRO N/A
- APLM $415.15
- Revenue Next Year
- CLRO N/A
- APLM N/A
- P/E Ratio
- CLRO N/A
- APLM N/A
- Revenue Growth
- CLRO N/A
- APLM N/A
- 52 Week Low
- CLRO $4.35
- APLM $4.47
- 52 Week High
- CLRO $21.00
- APLM $35.98
- Technical
- Relative Strength Index (RSI)
- CLRO 55.63
- APLM 48.06
- Support Level
- CLRO $9.75
- APLM $5.11
- Resistance Level
- CLRO $12.25
- APLM $6.56
- Average True Range (ATR)
- CLRO 1.24
- APLM 0.51
- MACD
- CLRO 0.21
- APLM -0.06
- Stochastic Oscillator
- CLRO 40.56
- APLM 52.54
About CLRO ClearOne Inc. (DE)
ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.
About APLM Apollomics Inc.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.